Rosemary E. Zuna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rosemary E. Zuna has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- Nicolas Wentzensen
Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA
6 shared publications - Joan L. Walker
Stephenson Cancer Center Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK
5 shared publications - Mark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland
5 shared publications Mark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
4 shared publicationsSophia S. Wang
Cancer Etiology, Beckman Institute, City of Hope, Duarte, California
4 shared publications- Richard A. Allen
Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA
3 shared publications
Latest Publications
- 1 July 2022
- Published by IGI Global Scientific Publishing
- p. 31-48
Algorithm Enhancements for Improvement of Localized Classification of Uterine Cervical Cancer Digital Histology Images
In prior research, the authors introduced an automated, localized, fusion-based approach for classifying squamous epithelium into Normal, CIN1, CIN2, and CIN3 grades of cervical intraepithelial neoplasia (CIN) from digitized histology image analysis. The image analysis approach partitioned the epithelium along the medial axis into ten vertical segments. Texture, cellularity, nuclear characterization and distribution, and acellular features were computed from each vertical segment. The individual vertical segments were CIN classified, and the individual classifications were fused to generate an image-based CIN assessment. In this chapter, image analysis techniques are investigated to improve the execution time of the algorithms and the CIN classification accuracy of the baseline algorithms. For an experimental data set of 117 digitized histology images, execution time for exact grade CIN classification accuracy was improved by 32.32 seconds without loss of exact grade CIN classification accuracy (80.34% vs. 79.49% previously reported) for this same data set. Request access from your librarian to read this chapter's full text.
- 1 July 2022
- Published by IGI Global Scientific Publishing
- p. 31-48
Algorithm Enhancements for Improvement of Localized Classification of Uterine Cervical Cancer Digital Histology Images
In prior research, the authors introduced an automated, localized, fusion-based approach for classifying squamous epithelium into Normal, CIN1, CIN2, and CIN3 grades of cervical intraepithelial neoplasia (CIN) from digitized histology image analysis. The image analysis approach partitioned the epithelium along the medial axis into ten vertical segments. Texture, cellularity, nuclear characterization and distribution, and acellular features were computed from each vertical segment. The individual vertical segments were CIN classified, and the individual classifications were fused to generate an image-based CIN assessment. In this chapter, image analysis techniques are investigated to improve the execution time of the algorithms and the CIN classification accuracy of the baseline algorithms. For an experimental data set of 117 digitized histology images, execution time for exact grade CIN classification accuracy was improved by 32.32 seconds without loss of exact grade CIN classification accuracy (80.34% vs. 79.49% previously reported) for this same data set. Request access from your librarian to read this chapter's full text.
- Open Access
- 28 February 2022
- Published by Scientific Scholar in Cytojournal
- Vol. 19, 9
Diagnostic Cytopathology of Peritoneal Washings
Peritoneal washings used for cytologic evaluation are collected at the outset of surgical exploration of women with gynecologic cancers to assist in determining extent of disease and follow-up therapy. While there are similarities to ascites, these samples have differences that must be recognized in order to avoid false positive interpretations. Non-neoplastic mesothelial alterations including heterogeneous reactive changes, endosalpingiosis , endometriosis and tumor rupture are typically not seen in ascites samples but can be seen in peritoneal washings from women with malignancies that have not extended to the peritoneal cavity. Awareness of these potential pitfalls and knowledge of the associated tumor type will facilitate accurate interpretation. When these caveats are recognized, peritoneal washing cytology results are a useful adjunct in helping to determine patient follow-up in women with gynecologic malignancies.
- 28 February 2022
- Published by Scientific Scholar in Cytojournal
- Vol. 19, 9
Open AccessDiagnostic Cytopathology of Peritoneal Washings
Peritoneal washings used for cytologic evaluation are collected at the outset of surgical exploration of women with gynecologic cancers to assist in determining extent of disease and follow-up therapy. While there are similarities to ascites, these samples have differences that must be recognized in order to avoid false positive interpretations. Non-neoplastic mesothelial alterations including heterogeneous reactive changes, endosalpingiosis , endometriosis and tumor rupture are typically not seen in ascites samples but can be seen in peritoneal washings from women with malignancies that have not extended to the peritoneal cavity. Awareness of these potential pitfalls and knowledge of the associated tumor type will facilitate accurate interpretation. When these caveats are recognized, peritoneal washing cytology results are a useful adjunct in helping to determine patient follow-up in women with gynecologic malignancies.
- Open Access
- 17 January 2022
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 46 (6) , 729-741
HPV51-associated Leiomyosarcoma
Inactivating mutations in tumor suppressor genes TP53 and RB1 are considered central drivers in leiomyosarcomas (LMSs). In high-risk human papillomavirus (HPV)-related tumors, a similar functional outcome is achieved through oncoproteins E6 and E7, which inactivate the p53 and RB1 proteins, respectively. Here, we hypothesized that HPV infection could provide an alternative mechanism for tumorigenesis in a subset of TP53/RB1-wildtype LMS. We evaluated tumor samples from 2585 consecutive unique patients carrying a diagnosis of gynecologic or soft tissue LMS. Tumor DNA and available RNA were analyzed by hybrid-capture-based next-generation sequencing/comprehensive genomic profiling of 406 genes and transcripts (FoundationOneHeme). Of the initial 2585 cases, we excluded 16 based on the presence of molecular alterations that are considered defining for sarcomas other than LMS. In the remaining 2569 cases, we searched for LMS that were TP53/RB1-wildtype (n=486 of 2569; 18.9%). We also searched LMS tumors for HPV sequences that we then classified into genotypes by de novo assembly of nonhuman sequencing reads followed by alignment to the RefSeq database. Among TP53/RB1-wildtype LMS, we identified 18 unique cases harboring HPV sequences. Surprisingly, most (n=11) were HPV51-positive, and these 11 represented all HPV51-positive tumors in our entire LMS database (n=11 of 2569; 0.4%). The absence of genomic alterations in TP53 or RB1 in HPV51-positive LMS represented a marked difference from HPV51-negative LMS (n=2558; 0% vs. 72% [PP=0.0002]). In addition, compared with HPV51-negative LMS, HPV51-positive LMS were significantly enriched for genomic alterations in ATRX (55% vs. 24%, P=0.027) and TSC1 (18% vs. 0.6%, P=0.0047). All HPV51-positive LMS were in women; median age was 54 years at surgery (range: 23 to 74 y). All known primary sites were from the gynecologic tract or adjacent anogenital area, including 5 cases of vaginal primary site. Histology was heterogeneous, with evaluable cases showing predominant epithelioid (n=5) and spindle (n=5) morphology. In situ hybridization confirmed the presence of high-risk HPV E6/E7 mRNA in tumor cells in three of three evaluable cases harboring HPV51 genomic sequences. Overall, in our pan-LMS analysis, HPV reads were identified in a subset of TP53/RB1-wildtype LMS. For all HPV51-associated LMS, the striking absence of any detectable TP53 or RB1 mutations and predilection for the female lower reproductive tract supports our hypothesis that high-risk HPV can be an alternative tumorigenic mechanism in this distinct class of LMS.
- 17 January 2022
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 46 (6) , 729-741
Open AccessHPV51-associated Leiomyosarcoma
Inactivating mutations in tumor suppressor genes TP53 and RB1 are considered central drivers in leiomyosarcomas (LMSs). In high-risk human papillomavirus (HPV)-related tumors, a similar functional outcome is achieved through oncoproteins E6 and E7, which inactivate the p53 and RB1 proteins, respectively. Here, we hypothesized that HPV infection could provide an alternative mechanism for tumorigenesis in a subset of TP53/RB1-wildtype LMS. We evaluated tumor samples from 2585 consecutive unique patients carrying a diagnosis of gynecologic or soft tissue LMS. Tumor DNA and available RNA were analyzed by hybrid-capture-based next-generation sequencing/comprehensive genomic profiling of 406 genes and transcripts (FoundationOneHeme). Of the initial 2585 cases, we excluded 16 based on the presence of molecular alterations that are considered defining for sarcomas other than LMS. In the remaining 2569 cases, we searched for LMS that were TP53/RB1-wildtype (n=486 of 2569; 18.9%). We also searched LMS tumors for HPV sequences that we then classified into genotypes by de novo assembly of nonhuman sequencing reads followed by alignment to the RefSeq database. Among TP53/RB1-wildtype LMS, we identified 18 unique cases harboring HPV sequences. Surprisingly, most (n=11) were HPV51-positive, and these 11 represented all HPV51-positive tumors in our entire LMS database (n=11 of 2569; 0.4%). The absence of genomic alterations in TP53 or RB1 in HPV51-positive LMS represented a marked difference from HPV51-negative LMS (n=2558; 0% vs. 72% [PP=0.0002]). In addition, compared with HPV51-negative LMS, HPV51-positive LMS were significantly enriched for genomic alterations in ATRX (55% vs. 24%, P=0.027) and TSC1 (18% vs. 0.6%, P=0.0047). All HPV51-positive LMS were in women; median age was 54 years at surgery (range: 23 to 74 y). All known primary sites were from the gynecologic tract or adjacent anogenital area, including 5 cases of vaginal primary site. Histology was heterogeneous, with evaluable cases showing predominant epithelioid (n=5) and spindle (n=5) morphology. In situ hybridization confirmed the presence of high-risk HPV E6/E7 mRNA in tumor cells in three of three evaluable cases harboring HPV51 genomic sequences. Overall, in our pan-LMS analysis, HPV reads were identified in a subset of TP53/RB1-wildtype LMS. For all HPV51-associated LMS, the striking absence of any detectable TP53 or RB1 mutations and predilection for the female lower reproductive tract supports our hypothesis that high-risk HPV can be an alternative tumorigenic mechanism in this distinct class of LMS.
- Open Access
Cervical Whole Slide Histology Image Analysis Toolbox
Cervical intraepithelial neoplasia (CIN) is regarded as a potential precancerous state of the uterine cervix. Timely and appropriate early treatment of CIN can help reduce cervical cancer mortality. Accurate estimation of CIN grade correlated with human papillomavirus (HPV) type, which is the primary cause of the disease, helps determine the patient’s risk for developing the disease. Colposcopy is used to select women for biopsy. Expert pathologists examine the biopsied cervical epithelial tissue under a microscope. The examination can take a long time and is prone to error and often results in high inter- and intra-observer variability in outcomes. We propose a novel image analysis toolbox that can automate CIN diagnosis using whole slide image (digitized biopsies) of cervical tissue samples. The toolbox is built as a four-step deep learning model that detects the epithelium regions, segments the detected epithelial portions, analyzes local vertical segment regions, and finally classifies each epithelium block with localized attention. We propose an epithelium detection network in this study and make use of our earlier research on epithelium segmentation and CIN classification to complete the design of the end-to-end CIN diagnosis toolbox. The results show that automated epithelium detection and segmentation for CIN classification yields comparable results to manually segmented epithelium CIN classification. This highlights the potential as a tool for automated digitized histology slide image analysis to assist expert pathologists.
Open AccessCervical Whole Slide Histology Image Analysis Toolbox
Cervical intraepithelial neoplasia (CIN) is regarded as a potential precancerous state of the uterine cervix. Timely and appropriate early treatment of CIN can help reduce cervical cancer mortality. Accurate estimation of CIN grade correlated with human papillomavirus (HPV) type, which is the primary cause of the disease, helps determine the patient’s risk for developing the disease. Colposcopy is used to select women for biopsy. Expert pathologists examine the biopsied cervical epithelial tissue under a microscope. The examination can take a long time and is prone to error and often results in high inter- and intra-observer variability in outcomes. We propose a novel image analysis toolbox that can automate CIN diagnosis using whole slide image (digitized biopsies) of cervical tissue samples. The toolbox is built as a four-step deep learning model that detects the epithelium regions, segments the detected epithelial portions, analyzes local vertical segment regions, and finally classifies each epithelium block with localized attention. We propose an epithelium detection network in this study and make use of our earlier research on epithelium segmentation and CIN classification to complete the design of the end-to-end CIN diagnosis toolbox. The results show that automated epithelium detection and segmentation for CIN classification yields comparable results to manually segmented epithelium CIN classification. This highlights the potential as a tool for automated digitized histology slide image analysis to assist expert pathologists.
- Open Access
- 1 June 2019
- Published by Elsevier in Papillomavirus Research
- Vol. 7, 67-74
Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women
- 1 June 2019
- Published by Elsevier in Papillomavirus Research
- Vol. 7, 67-74
Open AccessHuman papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women
- Open Access
- 23 October 2018
- Published by Wiley in Cancer Cytopathology
- Vol. 126 (11) , 950-958
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis
Background: New cervical cancers continue to be diagnosed despite the success of Papanicolaou (Pap) tests. In an effort to identify pitfalls that limit the diagnosis of adenocarcinoma, the authors reviewed the cytologic characteristics of endocervical adenocarcinomas in their patient population.Methods: Liquid‐based cytology slides from 45 women who had concurrent, histologically confirmed cervical adenocarcinomas were reviewed retrospectively and semiquantitatively for 25 key cytologic traits. The original sign‐out diagnosis, available clinical findings, and high‐risk human papillomavirus (HR HPV) results also were noted.Results: Abundant tumor cellularity, nuclear size from 3 to 6 times normal, abundant 3‐dimensional tumor cell groups, round cell shape, and cytoplasmic neutrophils characterized the 23 cases that were identified correctly as adenocarcinomas. Key reasons for undercalls included low tumor cellularity and low‐grade columnar morphology; these also tended to correlate with low‐grade or unusual adenocarcinoma variants on histology. Overall, 73% of adenocarcinomas had a concurrent positive HR HPV test.Conclusions: Most endocervical adenocarcinomas can be diagnosed accurately in cases with classical features, but some cases continue to be problematic when evaluated based on cytologic features alone. Reflex HPV testing may help increase Pap test sensitivity for challenging cases that have atypical glandular cells of undetermined significance. Occasional cases with negative HR HPV test results remain of concern.
- 23 October 2018
- Published by Wiley in Cancer Cytopathology
- Vol. 126 (11) , 950-958
Open AccessCytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis
Background: New cervical cancers continue to be diagnosed despite the success of Papanicolaou (Pap) tests. In an effort to identify pitfalls that limit the diagnosis of adenocarcinoma, the authors reviewed the cytologic characteristics of endocervical adenocarcinomas in their patient population.Methods: Liquid‐based cytology slides from 45 women who had concurrent, histologically confirmed cervical adenocarcinomas were reviewed retrospectively and semiquantitatively for 25 key cytologic traits. The original sign‐out diagnosis, available clinical findings, and high‐risk human papillomavirus (HR HPV) results also were noted.Results: Abundant tumor cellularity, nuclear size from 3 to 6 times normal, abundant 3‐dimensional tumor cell groups, round cell shape, and cytoplasmic neutrophils characterized the 23 cases that were identified correctly as adenocarcinomas. Key reasons for undercalls included low tumor cellularity and low‐grade columnar morphology; these also tended to correlate with low‐grade or unusual adenocarcinoma variants on histology. Overall, 73% of adenocarcinomas had a concurrent positive HR HPV test.Conclusions: Most endocervical adenocarcinomas can be diagnosed accurately in cases with classical features, but some cases continue to be problematic when evaluated based on cytologic features alone. Reflex HPV testing may help increase Pap test sensitivity for challenging cases that have atypical glandular cells of undetermined significance. Occasional cases with negative HR HPV test results remain of concern.
- Open Access
- 17 February 2018
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 218 (6) , 604.e1-604.e8
A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers
- 17 February 2018
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 218 (6) , 604.e1-604.e8
Open AccessA prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers
- 1 October 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (1) , 216
Clinical Factors Associated with Short- and Long-Term Survival in Low Grade Ovarian Carcinoma
- 1 October 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (1) , 216
Clinical Factors Associated with Short- and Long-Term Survival in Low Grade Ovarian Carcinoma
- 1 May 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 145 (2) , 291-297
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study
- 1 May 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 145 (2) , 291-297
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study
- 1 January 2017
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 6 (1) , 10-15
Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas
- 1 January 2017
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 6 (1) , 10-15
Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas